11896 results
-
List item
Human medicine European public assessment report (EPAR): Repaglinide Accord
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 22/12/2011,
, Revision: 7, Authorised, Last updated: 21/01/2022
Repaglinide Accord Nutritional and Metabolic … Repaglinide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord
Palonosetron, Vomiting; Nausea; Cancer
Date of authorisation: 26/05/2016,, Revision: 5, Authorised, Last updated: 13/01/2022
Palonosetron Accord Pathological Conditions … Palonosetron Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 9, Authorised, Last updated: 31/03/2022
Lenalidomide Accord Cancer Neoplasms Neoplasms … Lenalidomide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Bortezomib Accord
bortezomib, Multiple Myeloma
Date of authorisation: 20/07/2015,, Revision: 13, Authorised, Last updated: 25/03/2022
Bortezomib Accord Hemostatic Disorders Vascular … Bortezomib Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 16, Authorised, Last updated: 10/12/2021
Capecitabine Accord Cancer Neoplasms Colorectal … Capecitabine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Sunitinib Accord
sunitinib, Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors
Date of authorisation: 11/02/2021,
, , Revision: 1, Authorised, Last updated: 14/12/2021
Sunitinib Accord Cancer Neoplasms Neoplasms … Sunitinib Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Cinacalcet Accordpharma (updated)
cinacalcet hydrochloride, Hyperparathyroidism
Date of authorisation: 03/04/2020,, Revision: 3, Authorised, Last updated: 16/05/2023
Cinacalcet Accordpharma Endocrine System Diseases Parathyroid … cinacalcet Overview Cinacalcet Accordpharma is a medicine used to treat … no other cause. Cinacalcet Accordpharma contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Plerixafor Accord
Plerixafor, Multiple Myeloma; Hematopoietic Stem Cell Transplantation
Date of authorisation: 16/12/2022,, , Authorised, Last updated: 06/02/2023
Plerixafor Accord Lymphoproliferative Disorders Lymphatic … plerixafor Overview Plerixafor Accord is a medicine used to mobilise … same patient. Plerixafor Accord is used together with the … -
List item
Human medicine European public assessment report (EPAR): Fingolimod Accord (updated)
fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 25/06/2020,, Revision: 3, Authorised, Last updated: 17/05/2023
Fingolimod Accord Nervous System Diseases Autoimmune … fingolimod Overview Fingolimod Accord is a type of medicine known … remissions). Fingolimod Accord is used when the disease … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accord
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Dasatinib Accord Leukemia, Lymphoid Leukemia Neoplasms Lymphoproliferative … Dasatinib Accord … Public statement Dasatinib Accord (dasatinib) Withdrawal of … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accordpharma
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Dasatinib Accordpharma Leukemia, Lymphoid Leukemia Neoplasms Lymphoproliferative … Dasatinib Accordpharma … Public statement Dasatinib Accordpharma (dasatinib) Withdrawal of … -
List item
Human medicine European public assessment report (EPAR): Sorafenib Accord
Sorafenib tosilate, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 09/11/2022,, Authorised, Last updated: 25/11/2022
Sorafenib Accord Adenocarcinoma Neoplasms … Sorafenib Accord … EMEA/H/C/005921 Sorafenib Accord (sorafenib) An overview … -
List item
Human medicine European public assessment report (EPAR): Sitagliptin Accord
sitagliptin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 25/04/2022,, Authorised, Last updated: 21/07/2022
Sitagliptin Accord Diabetes Mellitus Glucose … Sitagliptin Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Ivabradine Accord
ivabradine hydrochloride, Angina Pectoris; Heart Failure
Date of authorisation: 22/05/2017,, Revision: 6, Authorised, Last updated: 01/03/2022
Ivabradine Accord Pathological Conditions … Ivabradine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Memantine Accord
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 03/12/2013,, Revision: 7, Authorised, Last updated: 13/01/2022
Memantine Accord Nervous System Diseases Central … Memantine Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Accord
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2012,, Revision: 7, Authorised, Last updated: 13/01/2022
Pioglitazone Accord Nutritional and Metabolic … Pioglitazone Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Caspofungin Accord
caspofungin acetate, Candidiasis; Aspergillosis
Date of authorisation: 11/02/2016,, Revision: 6, Withdrawn, Last updated: 20/08/2021
Caspofungin Accord Candidiasis Aspergillosis … Caspofungin Accord … the public Caspofungin Accord caspofungin This is a … -
List item
Human medicine European public assessment report (EPAR): Abiraterone Accord
abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 26/04/2021,, Authorised, Last updated: 05/05/2021
Abiraterone Accord Cancer Neoplasms Genital … Abiraterone Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Icatibant Accord
icatibant acetate, Angioedemas, Hereditary
Date of authorisation: 16/07/2021,, Authorised, Last updated: 06/09/2021
Icatibant Accord Cardiovascular Diseases Vascular … Icatibant Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Ibandronic acid Accord
ibandronic acid, Wounds and Injuries; Breast Diseases; Neoplastic Processes; Calcium Metabolism Disorders; Water-Electrolyte Imbalance
Date of authorisation: 18/11/2012,, Revision: 14, Authorised, Last updated: 05/01/2023
Ibandronic acid Accord Cancer Neoplasms Wounds … Ibandronic acid Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Accord
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016,, Revision: 9, Authorised, Last updated: 03/11/2022
Pemetrexed Accord Carcinoma, Bronchogenic Bronchial … Pemetrexed Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Accord
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019,, Revision: 5, Authorised, Last updated: 12/05/2022
Arsenic trioxide Accord Cancer Neoplasms Leukemia … Arsenic trioxide Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Pramipexole Accord
pramipexole dihydrochloride monohydrate, Parkinson Disease; Restless Legs Syndrome
Date of authorisation: 29/09/2011,, Revision: 10, Authorised, Last updated: 11/12/2020
Pramipexole Accord Nervous System Diseases Central … Pramipexole Accord … medicines are manufactured according to the same quality standards … -
List item
Human medicine European public assessment report (EPAR): Dimethyl fumarate Accord
dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis
Date of authorisation: 15/02/2023,, Authorised, Last updated: 22/02/2023
Dimethyl fumarate Accord Demyelinating Autoimmune … Overview Dimethyl fumarate Accord is a medicine used to treat … remissions). Dimethyl fumarate Accord is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Dabigatran Etexilate Accord (updated)
Dabigatran etexilate mesilate, Venous Thromboembolism; Arthroplasty, Replacement
Date of authorisation: 26/05/2023,, Authorised, Last updated: 31/05/2023
Dabigatran Etexilate Accord Cardiovascular Diseases Vascular … Overview Dabigatran Etexilate Accord is an anticoagulant medicine … children. Dabigatran Etexilate Accord is a ‘ A generic medicine …